Los puntos clave no están disponibles para este artículo en este momento.
The present findings enabled a better understanding of the changes in gut microbiota and the related Trp pathway in MDD. Alterations of the gut microbiota may have the potential as biomarkers for distinguishing MDD patients form HCs.
Lai et al. (Tue,) studied this question.